By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Dictionary
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Dictionary
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Stress-Induced Cognitive Decline Quantified: New Evidence Points to Dual Recovery Strategy

Stress-Induced Cognitive Decline Quantified: New Evidence Points to Dual Recovery Strategy

GMJ
Last updated: 28/07/2026 13:30
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Conceptual illustration of human brain with stress pathways and botanical compounds highlighted
Acute psychological stress reduces memory and attention test performance by approximately 20%, according to research. Botanical compounds like Rhodiola and Ashwagandha show promise for mitigation, but evidence remains preliminary—lifestyle interventions remain foundational. — Photo by www.kaboompics.com on Pexels (Pexels License)
SHARE
1 min read|118 words

Acute psychological stress measurably impairs memory and attention performance by approximately 20%, according to recent peer-reviewed neuroscience research. The impact reflects direct disruption of prefrontal cortex function via elevated cortisol levels triggered by hypothalamic-pituitary-adrenal (HPA) axis activation. While these deficits are significant, they remain temporary and recoverable.

Promisingly, botanical compounds including Rhodiola and Ashwagandha demonstrate neuroprotective potential through HPA-axis regulation, offering complementary support to conventional stress management. However, researchers emphasize that lifestyle foundations—adequate sleep, regular exercise, and balanced nutrition—remain the primary evidence-based defense against stress-related cognitive decline.

The findings suggest a tiered approach: establish foundational wellness habits first, then consider botanical interventions as adjunctive support. Current evidence warrants further standardization of botanical protocols before widespread clinical recommendation.

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Stress impairs memory and attention by up to 20%, study finds—but botanical interventions show promise →

Related reference
  • Ashwagandha · Ingredient
  • Rhodiola · Ingredient
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Ethiopia Study Reveals Stakeholder Concerns Over Novel Malaria Treatments

A qualitative study in Ethiopia reveals that health workers and patients view…

Sitafloxacin monotherapy matches doxycycline-rifampicin for brucellosis treatment in landmark trial

A multicenter randomized trial in The Lancet Regional Health – Western Pacific…

Ultra-processed foods linked to higher kidney cancer risk in large US study

A prospective analysis of over 300,000 US adults found that higher consumption…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Clinical UpdatesPolicy & SystemsPracticeQuality & Safety

CDC Identifies Shredded Lettuce as Source of Multistate Cyclosporiasis Outbreak

By
Prof. Giorgi Pkhakadze
18/07/2026
Medical professional reviewing chest X-ray with AI analysis highlighting bone density patterns

Revolutionary AI System Identifies Osteoporosis Risk Hidden in Routine Chest X-rays

By
Prof. Giorgi Pkhakadze
07/06/2026
Illustration of kidney transplant with donor bone marrow and regulatory T cell infusion protocol

Zero Myeloablative Conditioning: New Data Shows Radiation-Free Path to Transplant Tolerance

By
Prof. Giorgi Pkhakadze
26/07/2026
Laboratory illustration of antibodies neutralizing henipavirus particles

First Potential Treatment for Henipavirus Emerges From Dual-Antibody Strategy

By
Prof. Giorgi Pkhakadze
13/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?